Marker Therapeutics, Inc(NASDAQ:MRKR) 
Marker Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA-specific T cell technolog...
Website: http://www.markertherapeutics.com
Founded: 1992
Full Time Employees: 28
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.07
H 1.11
L 1.00
C 1.00
V 107,709
10EMA 1.00
20EMA 1.00
60EMA 1.00
120EMA 1.00
250EMA 1.00